NASDAQ: VTGN
Vistagen Therapeutics Inc Stock Ownership - Who owns Vistagen Therapeutics?

Insider buying vs selling

Have Vistagen Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Reid G. AdlerChief Legal Officer2026-06-3036,818$0.19
$7.07kBuy
Shawn SinghPresident and CEO2026-06-3036,818$0.19
$7.07kBuy
Nick B. TresslerChief Financial Officer2026-06-3011,712$0.19
$2.25kBuy
Joshua S. PrinceChief Operating Officer2025-12-314,386$0.56
$2.47kBuy

1 of 1

VTGN insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VTGN insiders and whales buy or sell their stock.

VTGN Shareholders

What type of owners hold Vistagen Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Venrock Healthcare Capital Partners II LP44.68%20,637,286$3.38MInsider
Holding Co Cato7.17%3,310,836$542.98kInsider
Platinum Long Term Growth VII LLC3.38%1,558,862$255.65kInsider
Commodore Capital LP1.73%799,244$131.08kInsider
Allen Easley Cato0.98%452,621$74.23kInsider
Jerry B. Gin0.87%400,000$65.60kInsider
A. Franklin Rice0.38%174,046$28.54kInsider
Shawn Singh0.27%122,830$20.14kInsider
H. Ralph Snodgrass0.21%98,859$16.21kInsider
Reid G. Adler0.13%60,868$9.98kInsider

1 of 3

VTGN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VTGN0.02%60.09%Net Buying
PHIO0.00%100.00%Net BuyingNet Buying
IMRN0.00%1.94%
CLRB0.05%33.61%Net Buying
DARE0.01%99.99%Net SellingNet Selling

Vistagen Therapeutics Stock Ownership FAQ

Who owns Vistagen Therapeutics?

Vistagen Therapeutics (NASDAQ: VTGN) is owned by 0.02% institutional shareholders, 60.09% Vistagen Therapeutics insiders, and 39.88% retail investors. Venrock Healthcare Capital Partners II LP is the largest individual Vistagen Therapeutics shareholder, owning 20.64M shares representing 44.68% of the company. Venrock Healthcare Capital Partners II LP's Vistagen Therapeutics shares are currently valued at $3.38M.

If you're new to stock investing, here's how to buy Vistagen Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.